In2Pharma
  • Home
  • Services
    • Regulatory Affairs
    • Quality Assurance
    • Publicity and Compliance
    • Medical writing & training
    • Vigilance
  • About Us
  • News
  • Contact
Select Page
Diploma for the Responsible Person for Information and Publicity (RIP)

Diploma for the Responsible Person for Information and Publicity (RIP)

by In2Pharma | Mar 22, 2023 | News

Belgium The Royal Decree of April 7, 1995 on information and publicity of medicinal products for human use, describing which diplomas are eligible for recognition as RIP is being amended. The adaptation is made to follow the evolution in terminology of the relevant...

Recent Posts

  • Updates to the Dutch Medicines Act
  • Update LCPV notification form
  • EC Regulation impacting pharmacovigilance
  • Recent Updates to GVP Guidance Documents
  • New hourly fees for the Netherlands for 2026

Follow Us

  • Facebook
  • LinkedIn
Privacy Policy | Cookie Policy | BTW BE 895730662 | +32 16 89 16 00| info@in2pharma.com | Terloonststraat 22, 1910 Kampenhout, België